Clinical Trials Browser

Terminated × Dermatofibrosarcoma × pazopanib × Clear all

NCT02601209 2022-08-23

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Phase 1/2 Terminated

151 enrolled 22 charts

Leiomyosarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT01059656 2016-07-01

DFSP-PAZO

Phase 2 Terminated

Dermatofibrosarcoma